401
Views
11
CrossRef citations to date
0
Altmetric
Original Research

Exploring Patients’ Attitudes Toward Deprescribing and Their Perception of Pharmacist Involvement in a European Country: A Cross-Sectional Study

ORCID Icon, , , &
Pages 2197-2208 | Published online: 23 Sep 2021

References

  • Midão L, Giardini A, Menditto E, Kardas P, Costa E. Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe. Arch Gerontol Geriatr. 2018;78:213–220. doi:10.1016/j.archger.2018.06.018
  • Khezrian M, McNeil CJ, Murray AD, Myint PK. An overview of prevalence, determinants and health outcomes of polypharmacy. Ther Adv Drug Saf. 2020;11:204209862093374. doi:10.1177/2042098620933741
  • Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1). doi:10.1186/s12877-017-0621-2
  • Assari B. Race/Ethnicity, socioeconomic status, and polypharmacy among older Americans. Pharmacy. 2019;7(2):41. doi:10.3390/pharmacy7020041
  • Zhang N, Sundquist J, Sundquist K, Ji J. An increasing trend in the prevalence of polypharmacy in Sweden: a nationwide register-based study. Front Pharmacol. 2020;11:326. doi:10.3389/fphar.2020.00326
  • Woodward MC. Deprescribing: achieving better health outcomes for older people through reducing medications. J Pharm Pract Res. 2003;33(4):323–328. doi:10.1002/jppr2003334323
  • Alldred DP. Deprescribing: a brave new word? Int J Pharm Pract. 2014;22(1):2–3. doi:10.1111/ijpp.12093
  • Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of “deprescribing” with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254–1268. doi:10.1111/bcp.12732
  • Potter K, Page A, Clifford R, Etherton-Beer C. Deprescribing: a guide for medication reviews. J Pharm Pract Res. 2016;46(4):358–367. doi:10.1002/jppr.1298
  • Martin P, Tamblyn R, Benedetti A, Ahmed S, Tannenbaum C. Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: the D-PRESCRIBE randomized clinical trial. J Am Med Assoc. 2018;320(18):1889–1898. doi:10.1001/jama.2018.16131
  • Bužančić I, Kummer I, Držaić M, Ortner‐Hadžiabdić M. Community‐based pharmacists’ role in deprescribing: a systematic review. Br J Clin Pharmacol. 2021;bcp14947. doi:10.1111/bcp.14947
  • Świeczkowski D, Merks P, Cwalina N, Jaguszewski M. Development of pharmacy practice in European Countries—The polish perspective. Pharmacy. 2017;5(4):43. doi:10.3390/pharmacy5030043
  • World Health Organization. Medication safety in transitions of care. WHO; 2019:52.
  • Bulajeva A, Labberton L, Leikola S, et al. Medication review practices in European countries. Res Soc Adm Pharm. 2014;10(5):731–740. doi:10.1016/j.sapharm.2014.02.005
  • Brajković A, Mucalo I, De Oliveira DR. Implementation of medication management services at the primary healthcare level - a pilot study. Acta Pharm. 2019;69(4):585–606. doi:10.2478/acph-2019-0055
  • Marinović I, Marušić S, Mucalo I, Mesarić J, Vrca VB. Clinical pharmacist-led program on medication reconciliation implementation at hospital admission: experience of a single university hospital in Croatia. Croat Med J. 2016;57(6):572–581. doi:10.3325/cmj.2016.57.572
  • Marinović I, Bačić Vrca V, Samardžić I, et al. Impact of an integrated medication reconciliation model led by a hospital clinical pharmacist on the reduction of post-discharge unintentional discrepancies. J Clin Pharm Ther. 2021. doi:10.1111/jcpt.13431
  • Murgic L, Hébert PC, Sovic S, Pavlekovic G. Paternalism and autonomy: views of patients and providers in a transitional (post-communist) country. BMC Med Ethics. 2015;16(1):65. doi:10.1186/s12910-015-0059-z
  • Vučemilo L, Ćurković M, Milošević M, Mustajbegović J, Borovečki A. Are physician-patient communication practices slowly changing in Croatia? - A cross-sectional questionnaire study. Croat Med J. 2013;54(2):185–191. doi:10.3325/cmj.2013.54.185
  • Kayyali R, Gebara SN, Hesso I, et al. Shared decision making and experiences of patients with long-term conditions: Has anything changed? BMC Health Serv Res. 2018;18(1):1–10. doi:10.1186/s12913-018-3575-y
  • Hughes TM, Merath K, Chen Q, et al. Association of shared decision-making on patient-reported health outcomes and healthcare utilization. Am J Surg. 2018;216(1):7–12. doi:10.1016/J.AMJSURG.2018.01.011
  • Aljumah K. Impact of pharmacist intervention using shared decision making on adherence and measurable depressed patient outcomes. Value Health. 2016;19(3):A19. doi:10.1016/J.JVAL.2016.03.410
  • Thompson W, Reeve E, Moriarty F, et al. Deprescribing: future directions for research. Res Soc Adm Pharm. 2019;15(6):801–805. doi:10.1016/j.sapharm.2018.08.013
  • Linsky A, Gellad W, Linder JA, Friedberg MW. Advancing the science of deprescribing: a novel comprehensive conceptual framework. J Am Geriatr Soc. 2019;67(10):2018–2022. doi:10.1111/jgs.16136
  • Todd A, Jansen J, Colvin J, McLachlan AJ. The deprescribing rainbow: a conceptual framework highlighting the importance of patient context when stopping medication in older people. BMC Geriatr. 2018;18(1):1–8. doi:10.1186/s12877-018-0978-x
  • Reeve E, Low LF, Shakib S, Hilmer SN. Development and validation of the revised Patients’ Attitudes Towards Deprescribing (rPATD) questionnaire: versions for older adults and caregivers. Drugs Aging. 2016;33(12):913–928. doi:10.1007/s40266-016-0410-1
  • Schiøtz ML, Frølich A, Jensen AK, et al. Polypharmacy and medication deprescribing: a survey among multimorbid older adults in Denmark. Pharmacol Res Perspect. 2018;6(6):e00431. doi:10.1002/prp2.431
  • Reeve E, Wiese MD, Hendrix I, Roberts MS, Shakib S. People’s attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. J Am Geriatr Soc. 2013;61(9):1508–1514. doi:10.1111/jgs.12418
  • Jia Hao L, Omar MS, Tohit N. Polypharmacy and willingness to deprescribe among elderly with chronic diseases. Int J Gerontol. 2018;12(4):340–343. doi:10.1016/j.ijge.2018.05.006
  • Galazzi A, Lusignani M, Chiarelli MT, et al. Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy. Int J Clin Pharm. 2016;38(2):454–461. doi:10.1007/s11096-016-0279-4
  • World Health Organization. Process of translation and adaptation of instruments. WHO; 2010.
  • Ailabouni N, Mangin D, Nishtala PS. DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities. Int J Clin Pharm. 2019;41(1):167–178. doi:10.1007/s11096-019-00784-9
  • Martin P, Tamblyn R, Ahmed S, Tannenbaum C. An educational intervention to reduce the use of potentially inappropriate medications among older adults (EMPOWER study): protocol for a cluster randomized trial. Trials. 2013;14(1):80. doi:10.1186/1745-6215-14-80
  • Tannenbaum C, Martin P, Tamblyn R, Benedetti A, Ahmed S. Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial. JAMA Intern Med. 2014;174(6):890–898. doi:10.1001/jamainternmed.2014.949
  • Elbeddini A, Zhang CXY. The pharmacist’s role in successful deprescribing through hospital medication reconciliation. Can Pharm J. 2019;152(3):177–179. doi:10.1177/1715163519836136
  • Ng WL, Tan MZW, Koh EYL, Tan NC. Deprescribing: what are the views and factors influencing this concept among patients with chronic diseases in a developed Asian community? Proc Singapore Healthc. 2017;26(3):172–179. doi:10.1177/2010105817699633
  • Matzke GR, Moczygemba LR, Williams KJ, Czar MJ, Lee WT. Impact of a pharmacist–physician collaborative care model on patient outcomes and health services utilization. Am J Heal Pharm. 2018;75(14):1039–1047. doi:10.2146/AJHP170789
  • Snyder ME, Zillich AJ, Primack BA, et al. Exploring successful community pharmacist-physician collaborative working relationships using mixed methods. Res Soc Adm Pharm. 2010;6(4):307–323. doi:10.1016/J.SAPHARM.2009.11.008
  • Potter EL, Lew TE, Sooriyakumaran M, Edwards AM, Tong E, Aung AK. Evaluation of pharmacist-led physician-supported inpatient deprescribing model in older patients admitted to an acute general medical unit. Australas J Ageing. 2019;38(3):206–210. doi:10.1111/AJAG.12643
  • Cheong ST, Ng TM, Tan KT. Pharmacist-initiated deprescribing in hospitalised elderly: prevalence and acceptance by physicians. Eur J Hosp Pharm. 2018;25(e1):e35–e39. doi:10.1136/EJHPHARM-2017-001251
  • Nusair MB, Arabyat R, Al-Azzam S, El-Hajji FD, Nusir AT, Al-Batineh M. Translation and psychometric properties of the Arabic version of the revised patients’ attitudes towards deprescribing questionnaire. J Pharm Health Serv Res. 2020;11(2):173–181. doi:10.1111/jphs.12340
  • Edelman M, Jellema P, Hak E, Denig P, Blanker MH. Patients’ attitudes towards deprescribing alpha-blockers and their willingness to participate in a discontinuation trial. Drugs Aging. 2019;36(12):1133–1139. doi:10.1007/s40266-019-00712-6
  • Sirois C, Ouellet N, Reeve E. Community-dwelling older people’s attitudes towards deprescribing in Canada. Res Soc Adm Pharm. 2017;13(4):864–870. doi:10.1016/j.sapharm.2016.08.006
  • Aoki T, Yamamoto Y, Ikenoue T, Fukuhara S. Factors associated with patient preferences towards deprescribing: a survey of adult patients on prescribed medications. Int J Clin Pharm. 2019;41(2):531–537. doi:10.1007/s11096-019-00797-4
  • Tegegn HG, Tefera YG, Erku DA, et al. Older patients’ perception of deprescribing in resource-limited settings: a cross-sectional study in an Ethiopia university hospital. BMJ Open. 2018;8(4):e020590. doi:10.1136/bmjopen-2017-020590
  • Kua KP, Saw PS, Lee SWH. Attitudes towards deprescribing among multi-ethnic community-dwelling older patients and caregivers in Malaysia: a cross-sectional questionnaire study. A comment. Int J Clin Pharm. 2019;41(5):1131–1132. doi:10.1007/s11096-019-00891-7
  • Reeve E, Low LF, Hilmer SN. Attitudes of older adults and caregivers in Australia toward deprescribing. J Am Geriatr Soc. 2019;67(6):1204–1210. doi:10.1111/jgs.15804
  • Australian Institute of Health and Welfare 2018. Australia's health 2018. Cat. no. AUS 221. Canberra: AIHW. doi:10.25816/5ec1e56f25480 Available from: https://www.aihw.gov.au/reports/australias-health/australias-health-2018/contents/indicators-of-australias-health/health-literacy. Accessed May 2, 2021.
  • Brangan S, Ivanišić M, Rafaj G, Rowlands G. Health literacy of hospital patients using a linguistically validated Croatian version of the Newest Vital Sign screening test (NVS-HR). PLoS One. 2018;13(2):e0193079. doi:10.1371/journal.pone.0193079
  • Scott S, Clark A, Farrow C, et al. Attitudinal predictors of older peoples’ and caregivers’ desire to deprescribe in hospital. BMC Geriatr. 2019;19(1):1–11. doi:10.1186/s12877-019-1127-x
  • Crutzen S, Abou J, Smits SE, et al. Older people’s attitudes towards deprescribing cardiometabolic medication. BMC Geriatr. 2021;21(1):366. doi:10.1186/s12877-021-02249-z
  • Wolters M, van Hulten R, Blom L, Bouvy ML. Exploring the concept of patient centred communication for the pharmacy practice. Int J Clin Pharm. 2017;39(6):1145–1156. doi:10.1007/s11096-017-0508-5
  • Martinez AI, Spencer J, Moloney M, Badour C, Reeve E, Moga DC. Attitudes toward deprescribing in a middle-aged health disparities population. Res Soc Adm Pharm. 2020;16(10):1502–1507. doi:10.1016/j.sapharm.2020.02.014